The FDA has approved an antibiotic called minocycline for the treatment of rosacea in adults. The drug, which is taken orally ...

Approval of the tetracycline antibiotic for this indication was supported by data from two multicenter phase III trials -- ...

Journey Medical has claimed FDA approval for its Emrosi therapy for rosacea, which it thinks could become a "standard of care ...

To improve symptoms, your eye care provider may recommend: Granulomatous rosacea is a less common type and causes firm, red, or yellowish bumps on the cheeks, chin, or around the eyes. Treatment ...

The U.S. Food and Drug Administration has approved Journey Medical's drug for the treatment of a long-term skin condition ...

Before I received a diagnosis of ocular rosacea—which translates ... given a vague diagnosis of malar rash. The treatment? A daily dose of the antibiotic doxycycline that was consistently ...

The US’ Food and Drug Administration (FDA) has approved Journey Medical’s Emrosi, the brand name for its 40mg minocycline hydrochloride extended-release capsules, to be used in the treatment ...

In addition to Oracea, Journey’s rosacea offering could rival Sol-Gel Technologies’ Galderma-partnered Epsolay, a topical medicine that won approval in 2022. That treatment option uses Sol-Gel ...

Rosacea is chronic and not curable, it is highly treatable and can be well-managed with over-the-counter products, treatments, medications or surgeries. It's important to speak with a ...